Tigam, Narcita M.

HRN: 04-68-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFTRIAXONE 1G (VIAL)
06/03/2022
06/09/2022
IV
2g
OD
Presumptive TB; UTI
Waiting Final Action 
06/05/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/05/2022
06/12/2022
IV
4.5g IV Now Then 2.25g IV Q6
4.5g Now Then 2.25g IV Q6
PTB Presumptive; S/P Intubation
Waiting Final Action 
06/10/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/10/2022
06/14/2022
IV
4.5 G
Q6
HAP On Top Of CAP
Waiting Final Action 
06/10/2022
LEVOFLOXACIN 500MG (TAB)
06/10/2022
06/16/2022
ORAL
750mg
OD
HAP On Top Of CAP
Waiting Final Action 
06/18/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/18/2022
06/25/2022
IVTT
1.5g
Q6
Pulmonary Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: